Medical Biotechnology and Molecular Medicine
Corso in presenza
Medical Biotechnology and Molecular Medicine
Scheda del corso
A.A. 2026/2027
Laurea magistrale
LM-9 R - Biotecnologie mediche, veterinarie e farmaceutiche
The Master's Degree Program in Medical Biotechnology and Molecular Medicine is designed to train professionals with a strong theoretical and technical background. Graduates are expected to pursue careers involving the development of advanced scientific methodologies and the coordination of research projects in the fields of applied biotechnology and translational medicine.
The program provides students with a solid foundation in the genetic and molecular bases of disease and in the pathophysiological mechanisms underlying human disorders, with the aim of developing biotechnology-based diagnostic and therapeutic strategies. This core training is complemented by specialized training in computer science, biophysics, nanotechnology and pharmacology.
The program is organized into common and curriculum-specific learning activities, with a focus on neuroscience, oncology, molecular diagnostics, immune-biotechnology, modelling and bioinformatics. Within the common courses, students also acquire knowledge of the economic management of scientific research projects, with particular emphasis on business plan development and cost analysis.
A substantial part of the program covering almost the entire second year is devoted to the degree internship. During this period, students attend a research laboratory where, under the supervision of a tutor, they develop an original research project. Within this framework, students design and carry out experimental work, applying a range of methodologies and approaches consistent with the objectives of the host research group. This activity is specifically intended to support the preparation of the final degree examination
The program provides students with a solid foundation in the genetic and molecular bases of disease and in the pathophysiological mechanisms underlying human disorders, with the aim of developing biotechnology-based diagnostic and therapeutic strategies. This core training is complemented by specialized training in computer science, biophysics, nanotechnology and pharmacology.
The program is organized into common and curriculum-specific learning activities, with a focus on neuroscience, oncology, molecular diagnostics, immune-biotechnology, modelling and bioinformatics. Within the common courses, students also acquire knowledge of the economic management of scientific research projects, with particular emphasis on business plan development and cost analysis.
A substantial part of the program covering almost the entire second year is devoted to the degree internship. During this period, students attend a research laboratory where, under the supervision of a tutor, they develop an original research project. Within this framework, students design and carry out experimental work, applying a range of methodologies and approaches consistent with the objectives of the host research group. This activity is specifically intended to support the preparation of the final degree examination
The objective of the program is to train experts in medical biotechnology and molecular medicine capable of developing novel experimental models for the study of human diseases, innovative diagnostic approaches, new therapeutic molecules, and advanced drug delivery systems. These competencies are grounded in a strong translational educational background, enabling graduates to act as an effective interface with clinical practice and to bridge basic research and patient care. A thorough understanding of the pathogenetic mechanisms underlying disease is essential for the application of basic sciences to the management of medical problems.
The program prepares graduates for the following professional profiles:
Medical Science Liaison (MSL) in pharmaceutical and biotechnological companies.
Within pharmaceutical and biotechnological companies, this professional profile is responsible for establishing and maintaining scientific relationships with clinicians and for supporting the appropriate use of company products. A strong background in medical sciences and pharmacology enables the Medical Science Liaison to interact effectively with physicians and to address clinical issues related to specific therapies.
Clinical Monitor in pharmaceutical and biotechnological companies or Contract Research Organizations (CROs) (upon completion of specific training programs).
Thanks to a solid background in pharmacology and statistics, this professional is qualified to coordinate and monitor clinical studies.
Market Access Manager in pharmaceutical and biotechnological companies, consulting agencies, or regulatory institutions such as the Italian Medicines Agency (AIFA) (upon completion of specific training programs).
Building on strong competencies in economics and pharmacology, as well as knowledge of ethical issues related to drug commercialization, graduates are well positioned to establish effective and stable interactions with regulatory authorities and institutions, with the aim of facilitating approval and market access for new pharmacological and biotechnological products.
Medical and Scientific Communication Advisor in scientific and medical communication agencies and publishing companies.
Owing to the multidisciplinary training acquired during the program, graduates may pursue careers as medical writers or consultants involved in the development of distance-learning modules for Continuing Medical Education (CME) and other continuing education programs for health professionals. They may also act as advisors for pharmaceutical and biotechnological companies in communication activities involving patient organizations.
Research Scientist.
Graduates may continue their training through PhD programs, second-level master?s degrees, or Schools of Specialization in fields such as Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, or Nutrition. Upon passing the State Board Examination, graduates may enroll in the Professional Register of Biologists (Senior Section).
Statistiche occupazionali (Almalaurea)
The program prepares graduates for the following professional profiles:
Medical Science Liaison (MSL) in pharmaceutical and biotechnological companies.
Within pharmaceutical and biotechnological companies, this professional profile is responsible for establishing and maintaining scientific relationships with clinicians and for supporting the appropriate use of company products. A strong background in medical sciences and pharmacology enables the Medical Science Liaison to interact effectively with physicians and to address clinical issues related to specific therapies.
Clinical Monitor in pharmaceutical and biotechnological companies or Contract Research Organizations (CROs) (upon completion of specific training programs).
Thanks to a solid background in pharmacology and statistics, this professional is qualified to coordinate and monitor clinical studies.
Market Access Manager in pharmaceutical and biotechnological companies, consulting agencies, or regulatory institutions such as the Italian Medicines Agency (AIFA) (upon completion of specific training programs).
Building on strong competencies in economics and pharmacology, as well as knowledge of ethical issues related to drug commercialization, graduates are well positioned to establish effective and stable interactions with regulatory authorities and institutions, with the aim of facilitating approval and market access for new pharmacological and biotechnological products.
Medical and Scientific Communication Advisor in scientific and medical communication agencies and publishing companies.
Owing to the multidisciplinary training acquired during the program, graduates may pursue careers as medical writers or consultants involved in the development of distance-learning modules for Continuing Medical Education (CME) and other continuing education programs for health professionals. They may also act as advisors for pharmaceutical and biotechnological companies in communication activities involving patient organizations.
Research Scientist.
Graduates may continue their training through PhD programs, second-level master?s degrees, or Schools of Specialization in fields such as Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, or Nutrition. Upon passing the State Board Examination, graduates may enroll in the Professional Register of Biologists (Senior Section).
Statistiche occupazionali (Almalaurea)
The Master's Degree Program in Medical Biotechnology and Molecular Medicine supports international mobility through collaborations with leading international universities and offers students the opportunity to earn academic credits through educational and training exchanges with partner institutions.
Available programs include:
- Bilateral agreements within the Erasmus+ framework with the University of Leuven (Katholieke Universiteit Leuven, Belgium), the Leiden University Medical Center (LUMC), University of Leiden (the Netherlands), and the University of Cantabria (Universidad de Cantabria, Spain);
- Traineeships at the Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland.
In recent years, an increasing number of students have enhanced their professional skills and strengthened the European dimension of their education through periods of study and research abroad. Partner universities are highly recognized European institutions, hosting well-established Master's and PhD programs in biomedical sciences and offering opportunities to conduct research across a broad range of scientific fields covered by the Degree Program. These experiences provide students with valuable opportunities to strengthen their curricula and to explore the possibility of pursuing an international career.
The Master's Degree Program in Medical Biotechnology and Molecular Medicine allows second-year students to complete their entire practical training for the preparation of the final thesis at one of the for ementioned partner institutions, or at other institutions with which a formal agreement has been established. Students are required to define a research project consistent with their course of study and curriculum, subject to joint approval by both the University of Milan tutor and the host institution tutor.
The period abroad has a duration of up to 9 months and corresponds to 32 ECTS credits. A positive evaluation of the period abroad is required and must be jointly issued by the host institution tutor and the University of Milan tutor and subsequently approved by the Degree Program Teaching Committee. Erasmus students who achieve outstanding results, as documented by the official evaluation letter from the host institution tutor addressed to the President of the Master's Degree Program Committee, may be awarded 1 additional point in the final degree grade.
In addition to general informational meetings organized by the University, the Degree Program in Medical Biotechnology and Molecular Medicine provides specific support to interested and selected students through dedicated information sessions and individual meetings with the mobility tutors.
Available programs include:
- Bilateral agreements within the Erasmus+ framework with the University of Leuven (Katholieke Universiteit Leuven, Belgium), the Leiden University Medical Center (LUMC), University of Leiden (the Netherlands), and the University of Cantabria (Universidad de Cantabria, Spain);
- Traineeships at the Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland.
In recent years, an increasing number of students have enhanced their professional skills and strengthened the European dimension of their education through periods of study and research abroad. Partner universities are highly recognized European institutions, hosting well-established Master's and PhD programs in biomedical sciences and offering opportunities to conduct research across a broad range of scientific fields covered by the Degree Program. These experiences provide students with valuable opportunities to strengthen their curricula and to explore the possibility of pursuing an international career.
The Master's Degree Program in Medical Biotechnology and Molecular Medicine allows second-year students to complete their entire practical training for the preparation of the final thesis at one of the for ementioned partner institutions, or at other institutions with which a formal agreement has been established. Students are required to define a research project consistent with their course of study and curriculum, subject to joint approval by both the University of Milan tutor and the host institution tutor.
The period abroad has a duration of up to 9 months and corresponds to 32 ECTS credits. A positive evaluation of the period abroad is required and must be jointly issued by the host institution tutor and the University of Milan tutor and subsequently approved by the Degree Program Teaching Committee. Erasmus students who achieve outstanding results, as documented by the official evaluation letter from the host institution tutor addressed to the President of the Master's Degree Program Committee, may be awarded 1 additional point in the final degree grade.
In addition to general informational meetings organized by the University, the Degree Program in Medical Biotechnology and Molecular Medicine provides specific support to interested and selected students through dedicated information sessions and individual meetings with the mobility tutors.
Students are required to attend all teaching activities, with a maximum allowance of 25% absence. Attendance must be recorded by signing in at each learning activity. In cases where absences exceed 25% of the scheduled hours, the Teaching Committee will take the appropriate measures.
Immatricolazione
Enrollment in this Master's Degree Program is limited, as admission is subject to a locally capped number of places. Italian and European applicants admitted to the program are selected through a ranking list based on the results of an admission test. The same ranking list may be also used for curriculum selection, in cases where student enrollment across the different curricula is not evenly distributed. To be eligible for enrollment and inclusion in the ranking list, applicants must achieve a minimum score of 20/50 on the admission test. Information regarding non-European applicants is provided below.* The date of the admission test will be announced in the official selection notice published on the University of Milan website.
For Italian and European applicants, selection is based on a competitive written entrance examination. The admission test consists of a multiple-choice written exam conducted in English and includes 50 questions covering subjects such as biology, biochemistry, physics, pharmacology, immunology, pathology, and genetics.
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), selection and ranking are based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview.
B2 entrance level:
Proficiency in English at level B2 or higher according to the Common European Framework of Reference for Languages (CEFR) is required for admission.
The B2-level requirement will be ascertained by the University Language Centre (SLAM) upon admission as follows:
- Valid language certificate at B2 level or higher, issued no more than three years before the application date. The list of language certificates recognized by the University is available at https://www.unimi.it/en/node/39322 .The certificate must be uploaded when submitting the online application;
- English level achieved during a University of Milan degree programme and certified by the University Language Centre (SLAM) no more than four years before the application date, including levels based on language certificates submitted by the applicant during their Bachelor?s degree at the University of Milan. Verification will be carried out automatically, no documents need to be uploaded.
- Entry test administrated by the University Language Centre (SLAM) according to the calendar published on the website: (https://www.unimi.it/en/node/39267/)
Applicants who fail to submit a valid certificate or do not meet the required proficiency level will be instructed during the admission procedure to take the Entry test.
Applicants who do not take or pass the Entry test will be required to obtain a language proficiency certificate recognized by the University (see https://www.unimi.it/en/node/39322) and submit it to SLAM via the InformaStudenti service by the deadline set by the master's degree programme (https://www.unimi.it/en/node/39267/).
Applicants who fail to meet the requirement by said deadline will not be admitted to the master's degree programme and may not sit any further tests." To be eligible for the entrance examination, applicants holding a Bachelor's degree from Italian or EU universities must have earned 180 ECTS credits. Of these, at least 50 ECTS credits must be obtained in the following scientific disciplinary areas: BIOS-06/A (Physiology), BIOS-07/A (Biochemistry), BIOS-08/A (Molecular Biology), BIOS-09/A (Clinical Biochemistry), BIOS-10/A (Biology), BIOS-11/A (Pharmacology), BIOS-12/A (Human Anatomy), BIOS-14/A (Genetics), BIOS-15/A (General Microbiology), MEDS-24/A (Medical Statistics), MEDS-01/A (Human Genetics), MEDS-02/A (General Pathology), MEDS-02/B (Clinical Pathology), MEDS-09/A (Medical Oncology), MEDS-03/A (Microbiology), MEDS-04/A (Pathology), MEDS-05/A (Internal Medicine), MEDS-11/A (Mental Health), MEDS-12/A (Neurology), MEDS-26/A (Laboratory Medicine), INF-01/A (Informatics), and PHYS-06/A (Medical Physics).
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), admission to the Master's Degree Program is based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview. As for Italian and EU applicants, non-EU candidates must have earned at least 50 ECTS credits in the scientific disciplinary areas listed above. In order to successfully attend the learning activities of the program, applicants are required to have a good mastery of spoken and written English. A B2 level of English proficiency is mandatory, and the relevant certification must be provided at the time of registration for the entrance examination.
Students waiting to obtain the bachelor's degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they obtain the bachelor degree by December 31th, also possessing the prerequisite described above. More details about the selection/admission procedure can be found above in the Admission Criteria paragraph.
For Italian and European applicants, selection is based on a competitive written entrance examination. The admission test consists of a multiple-choice written exam conducted in English and includes 50 questions covering subjects such as biology, biochemistry, physics, pharmacology, immunology, pathology, and genetics.
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), selection and ranking are based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview.
B2 entrance level:
Proficiency in English at level B2 or higher according to the Common European Framework of Reference for Languages (CEFR) is required for admission.
The B2-level requirement will be ascertained by the University Language Centre (SLAM) upon admission as follows:
- Valid language certificate at B2 level or higher, issued no more than three years before the application date. The list of language certificates recognized by the University is available at https://www.unimi.it/en/node/39322 .The certificate must be uploaded when submitting the online application;
- English level achieved during a University of Milan degree programme and certified by the University Language Centre (SLAM) no more than four years before the application date, including levels based on language certificates submitted by the applicant during their Bachelor?s degree at the University of Milan. Verification will be carried out automatically, no documents need to be uploaded.
- Entry test administrated by the University Language Centre (SLAM) according to the calendar published on the website: (https://www.unimi.it/en/node/39267/)
Applicants who fail to submit a valid certificate or do not meet the required proficiency level will be instructed during the admission procedure to take the Entry test.
Applicants who do not take or pass the Entry test will be required to obtain a language proficiency certificate recognized by the University (see https://www.unimi.it/en/node/39322) and submit it to SLAM via the InformaStudenti service by the deadline set by the master's degree programme (https://www.unimi.it/en/node/39267/).
Applicants who fail to meet the requirement by said deadline will not be admitted to the master's degree programme and may not sit any further tests." To be eligible for the entrance examination, applicants holding a Bachelor's degree from Italian or EU universities must have earned 180 ECTS credits. Of these, at least 50 ECTS credits must be obtained in the following scientific disciplinary areas: BIOS-06/A (Physiology), BIOS-07/A (Biochemistry), BIOS-08/A (Molecular Biology), BIOS-09/A (Clinical Biochemistry), BIOS-10/A (Biology), BIOS-11/A (Pharmacology), BIOS-12/A (Human Anatomy), BIOS-14/A (Genetics), BIOS-15/A (General Microbiology), MEDS-24/A (Medical Statistics), MEDS-01/A (Human Genetics), MEDS-02/A (General Pathology), MEDS-02/B (Clinical Pathology), MEDS-09/A (Medical Oncology), MEDS-03/A (Microbiology), MEDS-04/A (Pathology), MEDS-05/A (Internal Medicine), MEDS-11/A (Mental Health), MEDS-12/A (Neurology), MEDS-26/A (Laboratory Medicine), INF-01/A (Informatics), and PHYS-06/A (Medical Physics).
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), admission to the Master's Degree Program is based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview. As for Italian and EU applicants, non-EU candidates must have earned at least 50 ECTS credits in the scientific disciplinary areas listed above. In order to successfully attend the learning activities of the program, applicants are required to have a good mastery of spoken and written English. A B2 level of English proficiency is mandatory, and the relevant certification must be provided at the time of registration for the entrance examination.
Students waiting to obtain the bachelor's degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they obtain the bachelor degree by December 31th, also possessing the prerequisite described above. More details about the selection/admission procedure can be found above in the Admission Criteria paragraph.
Posti disponibili: 65 + 10 riservati a cittadini Extra UE
Bando di ammissione
Consulta il bando per scoprire le date e i contenuti del test e tutte le informazioni su come iscriverti.
Domanda di ammissione: dal 24/03/2026 al 25/08/2026
Domanda di immatricolazione: dal 17/09/2026 al 24/09/2026
Servizi online
Per approfondire:
Manifesto ed elenco insegnamenti
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | Inglese | PHYS-06/A |
| Applied pharmacology to biotechnology | 7 | 67 | Inglese | BIOS-11/A |
| Pathogenetic basis of diseases | 12 | 84 | Inglese | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Secondo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | Inglese | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human biochemistry | 9 | 76.5 | Inglese | BIOS-07/A |
| Molecular biology applied to biotechnology | 7 | 67 | Inglese | BIOS-08/A |
Terzo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Molecular diagnostics and therapy | 6 | 42 | Inglese | BIOS-10/A BIOS-11/A MEDS-12/A MEDS-26/D |
| Neurobiology | 6 | 42 | Inglese | BIOS-06/A BIOS-07/A BIOS-10/A MEDS-12/A |
| Pathogenetic bases of neurological and psychiatric disorders | 6 | 42 | Inglese | BIOS-08/A MEDS-08/A MEDS-11/A MEDS-12/A |
Regole di composizione
1° anno - In the first year, the student must gain 4 ects of further electives
sarà attivato dall'A.A. 2027/2028
annuale
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 48 | Inglese | NN |
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Social aspects of biotechnology | 11 | 77 | Inglese | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Attività conclusive
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Professionalizing training activities | 4 | 100 | Inglese | NN |
Attività conclusive
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Degree program final exam | 21 | 0 | Inglese | NN |
Regole di composizione
2° anno - In the second year, the student must gain 4 ects of further electives
Periodo non definito
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Facoltativo | ||||
| Additional language skills: italian (3 ECTS) | 3 | 0 | Italiano | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | Inglese | PHYS-06/A |
| Applied pharmacology to biotechnology | 7 | 67 | Inglese | BIOS-11/A |
| Pathogenetic basis of diseases | 12 | 84 | Inglese | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Secondo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | Inglese | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human biochemistry | 9 | 76.5 | Inglese | BIOS-07/A |
| Molecular biology applied to biotechnology | 7 | 67 | Inglese | BIOS-08/A |
Terzo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Cancer epidemiology and pathogenesis | 6 | 42 | Inglese | MEDS-02/A MEDS-09/A MEDS-09/B MEDS-24/A |
| Cancer immunology and microenvironment | 6 | 42 | Inglese | MEDS-02/A MEDS-09/A MEDS-09/B |
| Research and development of new diagnostic and therapeutic methodologies | 6 | 42 | Inglese | BIOS-08/A MEDS-04/A MEDS-09/B MEDS-26/D |
Regole di composizione
1° anno - In the first year, the student must gain 4 ects of further electives
sarà attivato dall'A.A. 2027/2028
annuale
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 48 | Inglese | NN |
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Social aspects of biotechnology | 11 | 77 | Inglese | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Attività conclusive
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Professionalizing training activities | 4 | 100 | Inglese | NN |
Attività conclusive
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Degree program final exam | 21 | 0 | Inglese | NN |
Regole di composizione
2° anno - In the second year, the student must gain 4 ects of further electives
Periodo non definito
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Facoltativo | ||||
| Additional language skills: italian (3 ECTS) | 3 | 0 | Italiano | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | Inglese | PHYS-06/A |
| Applied pharmacology to biotechnology | 7 | 67 | Inglese | BIOS-11/A |
| Pathogenetic basis of diseases | 12 | 84 | Inglese | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Secondo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | Inglese | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human biochemistry | 9 | 76.5 | Inglese | BIOS-07/A |
| Molecular biology applied to biotechnology | 7 | 67 | Inglese | BIOS-08/A |
Terzo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Advanced techniques in medical biotechnology | 6 | 42 | Inglese | BIOS-07/A BIOS-08/A BIOS-10/A MEDS-21/A |
| Data and laboratory management | 6 | 42 | Inglese | MEDS-24/A MEDS-25/A MEDS-26/A |
| Molecular diagnostics | 6 | 42 | Inglese | BIOS-09/A MEDS-01/A MEDS-03/A |
Regole di composizione
1° anno - In the first year, the student must gain 4 ects of further electives
sarà attivato dall'A.A. 2027/2028
annuale
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 48 | Inglese | NN |
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Social aspects of biotechnology | 11 | 77 | Inglese | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Attività conclusive
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Professionalizing training activities | 4 | 100 | Inglese | NN |
Attività conclusive
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Degree program final exam | 21 | 0 | Inglese | NN |
Regole di composizione
2° anno - In the second year, the student must gain 4 ects of further electives
Periodo non definito
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Facoltativo | ||||
| Additional language skills: italian (3 ECTS) | 3 | 0 | Italiano | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | Inglese | PHYS-06/A |
| Applied pharmacology to biotechnology | 7 | 67 | Inglese | BIOS-11/A |
| Pathogenetic basis of diseases | 12 | 84 | Inglese | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Secondo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | Inglese | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human biochemistry | 9 | 76.5 | Inglese | BIOS-07/A |
| Molecular biology applied to biotechnology | 7 | 67 | Inglese | BIOS-08/A |
Terzo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Cancer immunology and microenvironment | 6 | 42 | Inglese | MEDS-02/A MEDS-09/A MEDS-09/B |
| Experimental immunology and immunobiotechnology | 6 | 42 | Inglese | MEDS-02/A MEDS-09/C MEDS-26/A MVET-03/A |
| Transplantation and tissue engineering | 6 | 51 | Inglese | IBIO-01/A MEDS-06/A MEDS-09/B MEDS-25/A |
Regole di composizione
1° anno - In the first year, the student must gain 4 ects of further electives
sarà attivato dall'A.A. 2027/2028
annuale
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 48 | Inglese | NN |
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Social aspects of biotechnology | 11 | 77 | Inglese | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Attività conclusive
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Professionalizing training activities | 4 | 100 | Inglese | NN |
Attività conclusive
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Degree program final exam | 21 | 0 | Inglese | NN |
Regole di composizione
2° anno - In the second year, the student must gain 4 ects of further electives
Periodo non definito
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Facoltativo | ||||
| Additional language skills: italian (3 ECTS) | 3 | 0 | Italiano | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | Inglese | PHYS-06/A |
| Applied pharmacology to biotechnology | 7 | 67 | Inglese | BIOS-11/A |
| Pathogenetic basis of diseases | 12 | 84 | Inglese | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Secondo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | Inglese | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human biochemistry | 9 | 76.5 | Inglese | BIOS-07/A |
| Molecular biology applied to biotechnology | 7 | 67 | Inglese | BIOS-08/A |
Terzo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| In vitro and in vivo model systems for human diseases modeling | 6 | 42 | Inglese | BIOS-08/A BIOS-10/A BIOS-11/A MEDS-02/A |
| Multilevel computational modelling of human diseases | 6 | 42 | Inglese | BIOS-08/A CHEM-02/A PHYS-06/A |
| Spatial and molecular organization of cells in diseases | 6 | 42 | Inglese | BIOS-06/A BIOS-07/A BIOS-08/A PHYS-06/A |
Regole di composizione
1° anno - In the first year, the student must gain 4 ects of further electives
sarà attivato dall'A.A. 2027/2028
annuale
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 48 | Inglese | NN |
Primo trimestre
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Social aspects of biotechnology | 11 | 77 | Inglese | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Attività conclusive
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Professionalizing training activities | 4 | 100 | Inglese | NN |
Attività conclusive
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Obbligatorio | ||||
| Degree program final exam | 21 | 0 | Inglese | NN |
Regole di composizione
2° anno - In the second year, the student must gain 4 ects of further electives
Periodo non definito
Per queste attività non è previsto un periodo di offerta.
| Attività formative | Crediti massimi | Ore totali | Lingua | SSD |
|---|---|---|---|---|
| Facoltativo | ||||
| Additional language skills: italian (3 ECTS) | 3 | 0 | Italiano | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
Altre informazioni
Orientamento:
Info su ammissioni e immatricolazioni
- Contatta le segreterie
- Sportello online InformaStudenti
- Studenti internazionali: welcome desk
- Studenti con disabilità
- Studenti con DSA
Milano
Sedi didattiche
Both common learning activities and Curricular learning activities will be held at the Dipartimento di Biotecnologie Mediche e Medicina Traslazionale - Via Fratelli Cervi, 93 - 20054 Segrate.
Tutor per l'orientamento
Tutor per la mobilità internazionale e l'Erasmus
Tutor per stage e tirocini
Referente AQ del corso di studio
Strutture di riferimento
Contatti
- Student secretary: Mrs Lucia Loseto
Dip. Biotecnologie Mediche e Medicina Traslazionale sede di via Vanvitelli, 32
http://medicalbiotechnology.cdl.unimi.it/en
[email protected]
+390250317123
Le tasse universitarie per gli studenti iscritti ai corsi di laurea, di laurea magistrale e a ciclo unico sono suddivise in due rate:
- la prima rata ha importo uguale per tutti e si paga al momento dell’immatricolazione;
- la seconda rata varia in base al valore ISEE Università e al Corso di laurea;
- per gli studenti internazionali con redditi e patrimoni all’estero la seconda rata varia in base al Paese di provenienza
Diritto allo studio e altre agevolazioni
L’Ateneo prevede borse di studio, mense, alloggi e altre agevolazioni a favore dei propri studenti con specifici requisiti di merito e condizioni economiche.
Maggiori informazioni
Documenti ufficiali